Compare efficacy and safety of alpha1-blockers in patients with benign prostatic hyperplasia

Trial Profile

Compare efficacy and safety of alpha1-blockers in patients with benign prostatic hyperplasia

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Tamsulosin (Primary) ; Naftopidil
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Sep 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 03 Apr 2015 Status changed from recruiting to active, no longer recruiting, according to University Hospital Medical Information Network - Japan record.
    • 03 Apr 2015 Planned End Date changed from 31 Mar 2015 to 30 Sep 2014, according to University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top